share_log

Five Star Analyst Ratings

Benzinga ·  Nov 1, 2023 09:58
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
11/01/2023 31.58% Stephens & Co. $27 → $25 Maintains Overweight
07/25/2023 31.58% Stephens & Co. → $25 Reiterates Overweight → Overweight
04/27/2023 36.84% Stephens & Co. → $26 Reiterates → Overweight
04/25/2023 36.84% Stephens & Co. → $26 Reiterates → Overweight
10/28/2022 63.16% Stephens & Co. $30 → $31 Maintains Overweight
06/01/2021 52.63% Stephens & Co. → $29 Initiates Coverage On → Overweight
06/01/2021 63.16% DA Davidson → $31 Initiates Coverage On → Buy

What is the target price for Five Star (FSBC)?

The latest price target for Five Star (NASDAQ: FSBC) was reported by Stephens & Co. on November 1, 2023. The analyst firm set a price target for $25.00 expecting FSBC to rise to within 12 months (a possible 31.58% upside). 4 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Five Star (FSBC)?

The latest analyst rating for Five Star (NASDAQ: FSBC) was provided by Stephens & Co., and Five Star maintained their overweight rating.

When is the next analyst rating going to be posted or updated for Five Star (FSBC)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Five Star, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Five Star was filed on November 1, 2023 so you should expect the next rating to be made available sometime around November 1, 2024.

Is the Analyst Rating Five Star (FSBC) correct?

While ratings are subjective and will change, the latest Five Star (FSBC) rating was a maintained with a price target of $27.00 to $25.00. The current price Five Star (FSBC) is trading at is $19.00, which is out of the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment